AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank42
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
-7.86%
↓ 541% vs avg
Percentile
P42
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
1.78%
Historical baseline
PeriodValue
Q4 2025-7.86%
Q3 2025-11.33%
Q2 2025-6.78%
Q1 2025-11.67%
Q4 2024-5.73%
Q3 2024-9.95%
Q2 2024-10.54%
Q1 2024-12.60%
Q4 2023-9.79%
Q3 202355.48%
Q2 20238.61%
Q1 2023-11.19%
Q4 2022-6.77%
Q3 2022-8.34%
Q2 2022-0.40%
Q1 202284.49%
Q4 20210.00%
Q3 20210.00%
Q2 20210.00%
Q1 20210.00%